bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 15, 2024
Abstract
Aging,
the
predominant
risk
factor
for
numerous
diseases,
manifests
in
various
forms
across
structure
and
architecture
of
tissues
human
body,
offering
opportunity
to
quantify
interpret
tissue-specific
aging.
To
address
this,
we
present
a
comprehensive
assessment
tissue
changes
occurring
during
aging,
utilizing
vast
array
whole
slide
histopathological
images
from
Genotype-Tissue
Expression
Project
(GTEx).
We
analyzed
25,712
40
distinct
types
983
individuals,
applying
deep
learning
nuanced
morphological
that
undergo
with
age.
developed
‘tissue
clocks’—predictors
biological
age
based
on
images—which
achieved
mean
prediction
error
4.9
years
were
associated
telomere
attrition,
incidence
subclinical
pathologies,
comorbidities.
In
systematic
rates
organs,
identified
pervasive
non-uniform
aging
lifespan,
some
organs
exhibiting
earlier
(20–40
old)
others
showing
bimodal
patterns
age-related
changes.
also
uncovered
several
associations
between
demographic,
lifestyle,
medical
history
factors
acceleration
or
deceleration
age,
highlighting
potential
modifiable
influenced
process
at
level.
Finally,
by
combining
paired
histological
gene
expression
data,
strategy
predict
gaps
blood
samples.
This
approach
was
validated
external
cohorts
both
healthy
individuals
those
chronic
revealing
most
differentially
affected
disease
contexts.
work
offers
new
perspective
positioning
as
an
integrator
cellular
molecular
reflect
physiological
state
organs.
These
findings
underscore
value
imaging
tool
understanding
provide
foundation
exploration
processes
age-associated
diseases.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: March 23, 2024
Abstract
The
complex
biological
mechanisms
underlying
human
brain
aging
remain
incompletely
understood.
This
study
investigated
the
genetic
architecture
of
three
age
gaps
(BAG)
derived
from
gray
matter
volume
(GM-BAG),
white
microstructure
(WM-BAG),
and
functional
connectivity
(FC-BAG).
We
identified
sixteen
genomic
loci
that
reached
genome-wide
significance
(P-value
<
5×10
−8
).
A
gene-drug-disease
network
highlighted
genes
linked
to
GM-BAG
for
treating
neurodegenerative
neuropsychiatric
disorders
WM-BAG
cancer
therapy.
displayed
most
pronounced
heritability
enrichment
in
variants
within
conserved
regions.
Oligodendrocytes
astrocytes,
but
not
neurons,
exhibited
notable
WM
FC-BAG,
respectively.
Mendelian
randomization
potential
causal
effects
several
chronic
diseases
on
aging,
such
as
type
2
diabetes
AD
WM-BAG.
Our
results
provide
insights
into
genetics
with
clinical
implications
lifestyle
therapeutic
interventions.
All
are
publicly
available
at
https://labs.loni.usc.edu/medicine
.
The Innovation Medicine,
Journal Year:
2025,
Volume and Issue:
unknown, P. 100120 - 100120
Published: Jan. 1, 2025
<p>Artificial
intelligence
(AI)
is
driving
transformative
changes
in
the
field
of
medicine,
with
its
successful
application
relying
on
accurate
data
and
rigorous
quality
standards.
By
integrating
clinical
information,
pathology,
medical
imaging,
physiological
signals,
omics
data,
AI
significantly
enhances
precision
research
into
disease
mechanisms
patient
prognoses.
technologies
also
demonstrate
exceptional
potential
drug
development,
surgical
automation,
brain-computer
interface
(BCI)
research.
Through
simulation
biological
systems
prediction
intervention
outcomes,
enables
researchers
to
rapidly
translate
innovations
practical
applications.
While
challenges
such
as
computational
demands,
software
ethical
considerations
persist,
future
remains
highly
promising.
plays
a
pivotal
role
addressing
societal
issues
like
low
birth
rates
aging
populations.
can
contribute
mitigating
rate
through
enhanced
ovarian
reserve
evaluation,
menopause
forecasting,
optimization
Assisted
Reproductive
Technologies
(ART),
sperm
analysis
selection,
endometrial
receptivity
fertility
remote
consultations.
In
posed
by
an
population,
facilitate
development
dementia
models,
cognitive
health
monitoring
strategies,
early
screening
systems,
AI-driven
telemedicine
platforms,
intelligent
smart
companion
robots,
environments
for
aging-in-place.
profoundly
shapes
medicine.</p>
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(11)
Published: March 12, 2025
Brain
age
gap
(BAG),
the
deviation
between
estimated
brain
and
chronological
age,
is
a
promising
marker
of
health.
However,
genetic
architecture
reliable
targets
for
aging
remains
poorly
understood.
In
this
study,
we
estimate
magnetic
resonance
imaging
(MRI)–based
using
deep
learning
models
trained
on
UK
Biobank
validated
with
three
external
datasets.
A
genome-wide
association
study
BAG
identified
two
unreported
loci
seven
previously
reported
loci.
By
integrating
Mendelian
Randomization
(MR)
colocalization
analysis
eQTL
pQTL
data,
prioritized
genetically
supported
druggable
genes,
including
MAPT
,
TNFSF12
GZMB
SIRPB1
GNLY
NMB
C1RL
as
aging.
We
rediscovered
13
potential
drugs
evidence
from
clinical
trials
several
strong
support.
Our
provides
insights
into
basis
aging,
potentially
facilitating
drug
development
to
extend
health
span.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2023,
Volume and Issue:
unknown
Published: June 12, 2023
Abstract
Understanding
the
genetic
basis
of
biological
aging
in
multi-organ
systems
is
vital
for
elucidating
age-related
disease
mechanisms
and
identifying
therapeutic
interventions.
This
study
characterized
architecture
age
gap
(BAG)
across
nine
human
organ
377,028
individuals
European
ancestry
from
UK
Biobank.
We
discovered
393
genomic
loci-BAG
pairs
(P-value<5×10
-8
)
linked
to
brain,
eye,
cardiovascular,
hepatic,
immune,
metabolic,
musculoskeletal,
pulmonary,
renal
systems.
observed
BAG-organ
specificity
inter-organ
connections.
Genetic
variants
associated
with
BAGs
are
predominantly
specific
respective
system
while
exerting
pleiotropic
effects
on
traits
multiple
A
gene-drug-disease
network
confirmed
involvement
metabolic
BAG-associated
genes
drugs
targeting
various
disorders.
correlation
analyses
supported
Cheverud’s
Conjecture
1
–
between
mirrors
their
phenotypic
correlation.
causal
revealed
potential
linking
chronic
diseases
(e.g.,
Alzheimer’s
disease),
body
weight,
sleep
duration
BAG
Our
findings
shed
light
promising
interventions
enhance
health
within
a
complex
network,
including
lifestyle
modifications
drug
repositioning
strategies
treating
diseases.
All
results
publicly
available
at
https://labs-laboratory.com/medicine
.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 7, 2025
Abstract
Multi-organ
biological
aging
clocks
derived
from
clinical
phenotypes
and
neuroimaging
have
emerged
as
valuable
tools
for
studying
human
disease
1,2,3,4
.
Plasma
proteomics
provides
an
additional
molecular
dimension
to
enrich
these
5
Here,
we
used
2448
plasma
proteins
43,498
participants
in
the
UK
Biobank
develop
11
multi-organ
proteome-based
age
gaps
(ProtBAG).
We
compared
them
9
phenotype-based
(PhenoBAG
1
)
regarding
genetics,
causal
associations
with
525
endpoints
(DE)
FinnGen
PGC,
their
promise
predict
14
categories
mortality.
highlighted
critical
methodological
considerations
generating
ProtBAG,
including
need
bias
correction
6
addressing
protein
organ
specificity
enhance
model
performance
generalizability.
Genetic
analyses
revealed
overlap
between
ProtBAGs
PhenoBAGs,
shared
loci,
genetic
correlations,
colocalization
signals.
A
three-layer
network
linked
PhenoBAG,
DE,
exemplified
by
pathway
of
obesity→renal
PhenoBAG→renal
ProtBAG
holistically
understand
disease.
Combining
features
across
multiple
organs
improved
predictions
These
findings
provide
a
framework
integrating
multi-omics
biomedicine.
All
results
are
publicly
disseminated
at
https://labs-laboratory.com/medicine/
Pharmacological Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 107734 - 107734
Published: April 1, 2025
Drug
discovery
before
the
20th
century
often
focused
on
single
genes,
molecules,
cells,
or
organs,
failing
to
capture
complexity
of
biological
systems.
The
emergence
protein-protein
interaction
network
studies
in
2001
marked
a
turning
point
and
promoted
holistic
approach
that
considers
human
body
as
an
interconnected
system.
This
is
particularly
evident
study
bidirectional
interactions
between
central
nervous
system
(CNS)
peripheral
which
are
critical
for
understanding
health
disease.
Understanding
these
complex
requires
integrating
multi-scale,
heterogeneous
data
from
molecular
organ
levels,
encompassing
both
omics
(e.g.,
genomics,
proteomics,
microbiomics)
non-omics
imaging,
clinical
phenotypes).
Artificial
intelligence
(AI),
multi-modal
models,
has
demonstrated
significant
potential
analyzing
CNS-peripheral
by
processing
vast,
datasets.
Specifically,
AI
facilitates
identification
biomarkers,
prediction
therapeutic
targets,
simulation
drug
effects
multi-organ
systems,
thereby
paving
way
novel
strategies.
review
highlights
AI's
transformative
role
research,
focusing
its
applications
unraveling
disease
mechanisms,
discovering
optimizing
trials
through
patient
stratification
adaptive
trial
design.